Omalizumab biosimilar (IBC Generium)
奥马佐单抗生物类似药 (IBC Generium)
Report date: 2022/02/22 15:21:08
Base Information
Drug NameOmalizumab biosimilar (IBC Generium)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2022/02/09
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesIbc Generium
China Registration ClassN/A
Develop Information
Active CompaniesGenerium PharmaceuticalsIbc Generium
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A